Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, controlled trial of miglustat in Gaucher's disease type 3.
Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A. Schiffmann R, et al. Among authors: van schaik in. Ann Neurol. 2008 Nov;64(5):514-22. doi: 10.1002/ana.21491. Ann Neurol. 2008. PMID: 19067373 Free PMC article. Clinical Trial.
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial.
van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M. van Schaik IN, et al. Among authors: van der pol wl, van norden ag, van oostrom jc, van den berg lh, van doorn pa. Lancet Neurol. 2010 Mar;9(3):245-53. doi: 10.1016/S1474-4422(10)70021-1. Epub 2010 Feb 2. Lancet Neurol. 2010. PMID: 20133204 Clinical Trial.
FabryScan: a screening tool for early detection of Fabry disease.
Arning K, Naleschinski D, Maag R, Biegstraaten M, Kropp P, Lorenzen J, Hollak CE, van Schaik IN, Harten P, Zeuner RA, Binder A, Baron R. Arning K, et al. Among authors: van schaik in. J Neurol. 2012 Nov;259(11):2393-400. doi: 10.1007/s00415-012-6619-y. Epub 2012 Aug 10. J Neurol. 2012. PMID: 22878429
Comparison of CMT1A and CMT2: similarities and differences.
Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M. Bienfait HM, et al. Among authors: van engelen bg, van schaik in. J Neurol. 2006 Dec;253(12):1572-80. doi: 10.1007/s00415-006-0260-6. Epub 2006 Aug 28. J Neurol. 2006. PMID: 16941080
Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke.
Groot AE, van Schaik IN, Visser MC, Nederkoorn PJ, Limburg M, Aramideh M, de Beer F, Zwetsloot CP, Halkes P, de Kruijk J, Kruyt ND, van der Meulen W, Spaander F, van der Ree T, Kwa VI, Van den Berg-Vos RM, Roos YB, Coutinho JM. Groot AE, et al. Among authors: van den berg vos rm, van der meulen w, van der ree t, van schaik in. J Neurol. 2016 Apr;263(4):807-13. doi: 10.1007/s00415-016-8076-5. Epub 2016 Mar 5. J Neurol. 2016. PMID: 26946499 Free PMC article.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN, van Geloven N, Bril V, Hartung HP, Lewis RA, Sobue G, Lawo JP, Mielke O, Cornblath DR, Merkies IS; PATH study group. van Schaik IN, et al. Among authors: van geloven n. Trials. 2016 Jul 25;17(1):345. doi: 10.1186/s13063-016-1466-2. Trials. 2016. PMID: 27455854 Free PMC article. Clinical Trial.
167 results